CD274 and cancer: However, based on previous studies that examined the role of PD-L1 in cancer cells in human HNSCC samples [6,7], we postulate that the induction of PD-L1 by 5-FU might limit the adaptive immune response against cancer in patients receiving radio(chemo)therapy.